Purchase Order HHSN2682006MJ602597P

This is a $24,000.00 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a small disadvantaged business. The contract is for providing a hematology panel to perform sequencing of somatic mutations in bone marrow samples, which will provide guidance in the treatment and diagnosis of disease. The contract has an ultimate completion date of December 30,...

This is a $24,000 firm fixed-price purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Genomic Testing Cooperative, LCA, a small disadvantaged business located in Lake Forest, California. The contract is for specialized hematology panel testing and genomic sequencing services to analyze somatic mutations in bone marrow samples, in order to provide guidance for the treatment and diagnosis of disease....

This firm fixed-price purchase order, valued at $150,000.00, was awarded by the National Institute on Aging (NIA), which is part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Hjartavernd SES, a non-profit organization registered in Iceland. The purpose of the contract is to isolate DNA from the Age, Gene/Environment Susceptibility Reykjavik Study (AGES-RS) in preparation for a potential study on methylation, which will require AGES-RS baseline...

This is a $94,600 firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Aeon Technologies, L.L.C., a minority-owned, small disadvantaged business, for assaying homocysteine in frozen blood samples from the Healthy Aging in Neighborhoods of Diversity Across the Life Span (HANDLS) study. The purpose is to analyze changes in homocysteine levels over time and their relationship to health disparities, without introducing biases from using different...

This is a $24,940 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit genomics and molecular biology services company. The contract is to provide plasma protein detection services using a proteomics platform to support NHLBI's ongoing clinical protocol for sickle cell disease research. The contract period of performance is from June 15, 2025 to December 14, 2025. No set-aside designation was...

This is a $105,300.00 firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) to the Trustees of Boston University for DNA extraction services on 3,000 samples for the Framingham Heart Study (FHS). The contract has a completion date of January 4, 2025 and was awarded on January 5, 2024. The contract does not have a set-aside designation. As a leading private...

This is a firm-fixed-price purchase order contract awarded by the Office of Logistics and Acquisition Operations of the U.S. Department of Health and Human Services (HHS) to Allama Iqbal Medical Research Centre, a foreign government entity registered in the System for Award Management (SAM). The contract, valued at $105,000.00, is for DNA collection and analysis services to be performed in Bethesda, Maryland, USA. This is not a set-aside contract. Through past federal contract awards and grant...

This federal contract award from the Department of Health and Human Services' National Heart, Lung, and Blood Institute to Duke University Office of Research Administration Division is a $25,000 purchase order to measure hemoglobin adducts of nitrated polycyclic aromatic hydrocarbons in red blood cell biospecimens from the Shanghai Women's Health Study. The effort aims to further understanding of nitrated polycyclic aromatic hydrocarbons, which have emerged as a significant factor in disease...

This federal contract award is for $24,940.00 and was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit manufacturer of genomics and molecular biology services. The contract is a Firm Fixed Price Purchase Order to provide the NHLBI's Sickle Cell Branch with the Olink assay, which will be used to study the profiling of plasma proteins among individuals with sickle cell disease. The contract has no set-aside designation and is...

This is a $24,940 firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, to Psomagen Inc., a for-profit manufacturer of goods. The contract is for high-throughput, sensitive, and specific protein quantification analysis to maintain the integrity of Batch 3 of sickle cell disease (SCD) patient samples for the NHLBI's Laboratory of Sickle Cell Genetics and Pathophysiology....